immunotherapy
Longevity Lab
FDA approves first DNA-based HPV treatment with delivery device concerns
FDA approves Voceryq, the first DNA-based immunotherapy for HPV-driven recurrent respiratory papillomatosis (RRP), offering hope for patients avoiding repeated
Recovery Mode
Tumors Hide p53 Mutations from T Cells, Study Finds
Tumors can hide p53 mutations from T cells, posing challenges for personalized immunotherapy. Researchers find tumors conceal p53 neoantigens, making detection